USPTO trademark

OPTIMIZATION-BY-DESIGN

AllowedUSPTOWord markClass 5Class 35Class 40Class 42

"OPTIMIZATION-BY-DESIGN" is a word mark owned by Andelyn Biosciences, Inc., filed at the USPTO on March 17, 2025. It has been allowed and covers classes 5, 35, 40 and 42.

View Andelyn Biosciences, Inc. portfolioGet this data via the API
Official USPTO record
OPTIMIZATION-BY-DESIGN trademark as filed
As filed with the USPTO
Status
Allowed
Since September 9, 2026
Filed
March 17, 2025
Registered
Not yet
Expires
Not recorded
Application no.
99087625
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
4 classes
Ownership

Who owns OPTIMIZATION-BY-DESIGN

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Andelyn Biosciences, Inc.

Columbus, United States

14 trademarks in the portfolioView company

Representative

Ajay Jagtiani

Miles & Stockbridge P.C.

Goods and services

What the mark covers

The products and services OPTIMIZATION-BY-DESIGN is filed for, grouped by Nice class.

  • Pharmaceutical preparations, biological preparations, and gene therapy products, namely, genetically engineered tissues for transplant purposes for medical or pharmaceutical purposes, namely, viral vector vaccines, and nucleic-acids delivery products for use in the treatment of genetic diseases and disorders; all the foregoing not relating to restorative components for dental implants and dental restoration systems

  • Business collaboration services, namely, providing a national computer-based networking web site for medical researchers to collaborate across disciplines to contract for development and manufacture of gene therapy and pharmaceutical products; all the foregoing not relating to restorative components for dental implants and dental restoration systems

  • Manufacturing services for others in the field of pharmaceuticals, biopharmaceuticals, health care products and medical products; treatment of materials, namely, pharmaceutical and chemical products and their components used in the manufacture of pharmaceuticals and biopharmaceuticals; manufacture of pharmaceuticals and biopharmaceuticals to order and/or specification of others; contract manufacturing of pharmaceuticals, cells and gene therapy reagents; all the foregoing not relating to restorative components for dental implants and dental restoration systems

  • Product development for others relating to pharmaceuticals, biopharmaceuticals; scientific and technological consulting services, namely, research and design in the field of pharmaceutical industry; product testing and research in the field of pharmaceuticals, biopharmaceuticals; industrial research in the field of pharmaceuticals, biopharmaceuticals; pharmaceutical and biopharmaceutical drug development services; pharmaceutical and biopharmaceutical research and development; product development consultation; product research services, namely, providing analytical product testing, biosafety product testing and laboratory services for the production of pharmaceutical preparations for others; scientific and technical product development consulting for the pharmaceutical industry; research services in the field of pharmaceuticals; custom design and development of chemical reagents and biochemical assays; providing online non-downloadable computer software platform for users to access an integrated set of scientific and technical software capabilities, namely, software for enterprise resource planning, quality management, document management and sharing, learning management, laboratory information management, computerized maintenance management and data capture, built with quality and security in mind to deliver value to customers through the productization of data, adoption of advanced technologies, and focusing on collaborative total experience; all the foregoing not relating to restorative components for dental implants and dental restoration systems

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Teas post publication amendment received
  2. Notice of approval of extension request e-mailed
  3. Sou extension 1 granted
  4. Sou extension 1 filed
  5. Sou teas extension received
  6. Noa e-mailed - sou required from applicant
  7. Official gazette publication confirmation e-mailed
  8. Published for opposition
  9. Notification of notice of publication e-mailed
  10. Approved for pub - principal register

10 earlier steps on the official record.

FAQ

About OPTIMIZATION-BY-DESIGN

Who owns the trademark "OPTIMIZATION-BY-DESIGN"?

The USPTO trademark "OPTIMIZATION-BY-DESIGN" (application 99087625) is owned by Andelyn Biosciences, Inc.

What is the status of "OPTIMIZATION-BY-DESIGN"?

Its status at the USPTO is: allowed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull OPTIMIZATION-BY-DESIGN and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2a8f-3fe3-76d4-b81a-4e6f643b7300
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2a8f-3fe3-76d4-b81a-4e6f643b7300",
  "object": "trademark",
  "mark_text": "OPTIMIZATION-BY-DESIGN",
  "status": {
    "primary": "pending",
    "stage": "allowed"
  },
  "office_code": "US",
  "application_number": "99087625",
  "filing_date": "2025-03-17",
  "nice_classes": [
    5,
    35,
    40,
    42
  ],
  "owners": [
    {
      "name": "Andelyn Biosciences, Inc.",
      "entity_id": "ent_019eb70b-b4b7-709b-b8da-17ef017f1a56"
    }
  ]
}